By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Euthymics Bioscience, Inc. 

Continental Plaza
433 Hackensack Avenue
Hackensack  New Jersey  07601  U.S.A.
Phone: 201-968-0980 Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Euthymics Bioscience, Inc. Reports Top-Line Results from TRIADE Trial of Amitifadine for Major Depressive Disorder 5/29/2013 10:29:41 AM
Euthymics Bioscience, Inc. Completes Enrollment in TRIADE, Its Advanced Trial of Amitifadine for Major Depressive Disorder 10/11/2012 10:09:55 AM
Euthymics Bioscience, Inc. Initiates Clinical Trial for New Drug Targeted for Adult Attention Deficit Hyperactivity Disorder (ADHD) 3/22/2012 6:35:07 AM
Euthymics Bioscience, Inc. Presents Data That Support Advancing EB-1020 into Clinical Trials for Adult ADHD 12/7/2011 6:35:32 AM
Euthymics Bioscience, Inc. Appoints Dr. Randall Marshall, Leader in the Psychiatric Field, as Executive Director, Medical Affairs 11/9/2011 7:24:12 AM
Euthymics Bioscience, Inc. Appoints Biotech Industry Veteran Thomas A. Shea as CFO and Announces Additional Senior Management Appointments 6/28/2011 11:32:24 AM
Euthymics Bioscience, Inc. Initiates Triade Trial for Major Depression 3/14/2011 9:16:38 AM
Euthymics Bioscience, Inc. Bumps Series A to $28 Million 3/9/2011 6:31:07 AM
Euthymics Bioscience, Inc. Presents Phase II Data for EB-1010 in Major Depression at ACNP Annual Meeting 12/8/2010 8:51:33 AM
Euthymics Bioscience, Inc. Appoints Industry Veterans Dr. Pierre Tran, Joan Manthis and William Pappafotopoulos to Senior Management Team 8/18/2010 9:14:52 AM
12
//-->